Clinical Trial

Periodontal Disease and Salivary Mitofusin Levels

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 19, 2024 (before its estimated August 25, 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of this observational study is to find out whether there is a level difference in salivary mitofusin-1 and mitofusin-2 levels due to changes in periodontal status. The main question it aims to answer is: * Do salivary mitofusin-1 and mitofusin-2 levels of periodontitis patients differ from healthy patients? * Could salivary mitofusin-1 and mitofusin-2 levels be biomarkers for periodontal disease? Biochemical analysis will be performed on saliva samples taken at once from gingivitis or periodontitis patients and healthy individuals who apply to the periodontology clinic, at the initial stage of the treatment. There is no ongoing monitoring or second sampling.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06510608
Lead Sponsor Erzincan University
Conditions Periodontitis, Periodontal Diseases, Gingivitis
Enrollment 81 participants
Start Date 2024-07-25
Primary Completion 2024-08-25 (estimated)
Study Completion 2024-09-25 (estimated)
Updated on ClinicalTrials.gov 2024-07-19